Ruth Coll
Impact in
Papers in
- Genetics 12
- Mesenchymal stem cell research 7
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
-
- Osteoarthritis Treatment and Mechanisms 2
- Co-authors
- Joaquim Vives (11 shared papers)Margarita Codinach (9 shared papers)Joan García‐López (5 shared papers)Ramon Lopez Perez (1 shared paper)Marina Huguet (1 shared paper)Lluís Orozco (1 shared paper)Robert Soler (1 shared paper)Luciano Rodrı́guez (6 shared papers)
- Journals
- Cytotherapy (3 papers)Vox Sanguinis (2 papers)Blood (2 papers)Frontiers in Cardiovascular Medicine (1 paper)EBioMedicine (1 paper)
- Partner nations
- SpainUnited KingdomGermany
In The Last Decade
Ruth Coll
23 papers receiving 811 citations
Ruth Coll's Hit Papers
Peers
Comparison fields: 5 of 82
- Genetics 242
- Urology 83
- Surgery 351
- Rheumatology 87
- Hematology 41
Countries citing papers authored by Ruth Coll
This map shows the geographic impact of Ruth Coll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Coll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Coll more than expected).
Fields of papers citing papers by Ruth Coll
This network shows the impact of papers produced by Ruth Coll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Coll. The network helps show where Ruth Coll may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruth Coll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial Hit paper breakdown → | 2020 | 344 |
| 2 | 2016 | 150 | |
| 3 | 2020 | 91 | |
| 4 | 2020 | 44 | |
| 5 | 2020 | 30 | |
| 6 | 2024 | 27 | |
| 7 | 2012 | 23 | |
| 8 | 2013 | 22 | |
| 9 | 2016 | 16 | |
| 10 | 2020 | 12 | |
| 11 | 2021 | 12 | |
| 12 | 2021 | 10 | |
| 13 | 2012 | 9 | |
| 14 | 2012 | 9 | |
| 15 | 2015 | 6 | |
| 16 | Comparative activity of three new fluoroquinolones. | 1987 | 5 |
| 17 | 2024 | 5 | |
| 18 | 2025 | 4 | |
| 19 | 2022 | 2 | |
| 20 | 2022 | 1 |
About Ruth Coll
Ruth Coll is a scholar working on Genetics, Rheumatology, Surgery, Dermatology and Pathology and Forensic Medicine, having authored 24 papers that have together received 825 indexed citations. Recurring topics across this work include Mesenchymal stem cell research (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Osteoarthritis Treatment and Mechanisms (2 papers), Bone fractures and treatments (2 papers), Dermatology and Skin Diseases (2 papers), Biomedical Ethics and Regulation (2 papers), Tissue Engineering and Regenerative Medicine (2 papers) and Food Allergy and Anaphylaxis Research (1 paper). The work is most often cited by research in Genetics (242 citations), Urology (83 citations), Surgery (351 citations), Rheumatology (87 citations) and Hematology (41 citations). Ruth Coll has collaborated with scholars based in Spain, United Kingdom and Germany. Frequent co-authors include Joaquim Vives, Margarita Codinach, Joan García‐López, Ramon Lopez Perez, Marina Huguet, Lluís Orozco, Robert Soler, Luciano Rodrı́guez, Margarita Vallès and Joan Vidal. Their work appears in journals such as Cytotherapy, Vox Sanguinis, Blood, Frontiers in Cardiovascular Medicine and EBioMedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.